Abstract
Remethylation of homocysteine to methionine is dependent on an adequate supply of one or more of the B vitamins like folate, vitamin B12 and vitamin B6. Plasma total homocysteine (tHcy) is also influenced by genetic factors such as polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene. MTHFR is a flavo enzyme and a key player in folate metabolism and changes in its activity could modify the susceptibility to Acute Lymphoblastic Leukemia (ALL). In this case — control study we have examined the effect of riboflavin status as measured by erythrocyte glutathione reductase activation coefficient (EGRAC) on homocysteine levels along with vitamin B12 and folate in pediatric ALL. Folate and B12 levels were significantly lower among cases as compared to controls while EGRAC and tHcy did not differ significantly among the groups. The multivariate regression analysis revealed that in the ALL group EGRAC significantly influences tHcy levels suggesting that riboflavin availability may be a predictor of tHcy levels in patients with ALL. This finding may have implications for tHcy lowering therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McNulty H, McKinley MC, Wilson B, Mcparlin J, Strain JJ, Weir DG, et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implication for riboflavin requirements. Am J Clin Nutr 2002; 76: 436–441.
Kumar J, Das SK, Sharma P, Karthikeyan G, Ramakrishnan L, Sengupta S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 2005; 50: 655–663.
Guenther BD, Sheppard CA, Tran P, Rozen R, Mathews RG, Ludwig ML. The structure and properties of MTHFR from E.coli suggests how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol 1999; 6: 359–365.
Frantzen F, Faaren AL, Alfheim I, Nordha AK. An Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998; 44(22): 311–316.
Sauberlich HE, Judd JH, Nichoalds GE, Broquist HP, Darby WJ. Application of the EGR assay in evaluating riboflavin nutritional status in a high school student population. Am J Clin Nutr 1972; 25: 756–762.
Chen IW, Silberstein EB, Maxon HR, Volle CP, Sohnlein BH. Semi automated system for simultaneous assay of serum Vitamin B12 and Folic acid in serum evaluated. Clin Chem 1982; 28(10): 2161–2165.
Stanislawska-Sachadyn A, Woodside JV, Brown KS, Young IS, Murray L, McNulty H. Evidence for sex differences in the determinants of homocysteine concentrations. Mol Genet Metabol 2008; 93: 355–362.
Hustad S, Schneede J, Ueland PM. Riboflavin and Methylenetetrahydrofolate reductase in MTHFR polymorphisms and Disease, ed: Ueland PM, Rozen R. Landes Bioscience, Georgetown, Texas 2005: 71–77.
Hustad S, Ueland PM, Vollset SE, Zhang Y, Monsen-Bjorke AL, Schneede J. Riboflavin as a determinant of plasma total homocysteine: Effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem 2000; 46: 1065–1071.
Jacques PF, Kalmbach R, Bagley PJ. The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr 2002;132: 283–288.
Skoupy S, Fodinger M, Veitl M, Perschl A, Puttinger H, Rohrer C, et al. Riboflavin is a Determinant of Total Homocysteine Plasma Concentrations in End-Stage Renal Disease Patients. J Am Soc Nephol 2002; 13:1331–1337.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sadananda Adiga, M.N., Chandy, S., Ramaswamy, G. et al. Association between plasma homocysteine and riboflavin status in Acute Lymphoblastic Leukemia in children. Indian J Clin Biochem 24, 257–261 (2009). https://doi.org/10.1007/s12291-009-0048-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-009-0048-4